We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+8.98%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$543M
AUM Growth
-$13.1M
Cap. Flow
-$12.1M
Cap. Flow %
-2.23%
Top 10 Hldgs %
68.19%
Holding
65
New
6
Increased
25
Reduced
15
Closed
8
Avg Time Held
7.6 quarters
Top 10 Avg Time Held
7.2 quarters
Top 20 Avg Time Held
7.4 quarters

Top Buys

Rank Stock Value
1
IREN icon
Iris Energy
IREN
+$7.74M
2
LMND icon
Lemonade
LMND
+$6.94M
3
VRDN icon
Viridian Therapeutics
VRDN
+$4.76M
4
BIIB icon
Biogen
BIIB
+$3.52M
5
ENGN icon
enGene Therapeutics
ENGN
+$2.82M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$16.9M
2
TSLA icon
Tesla
TSLA
+$6.87M
3
AMZN icon
Amazon
AMZN
+$6.41M
4
ARWR icon
Arrowhead Research
ARWR
+$3.71M
5
SE icon
Sea Limited
SE
+$3.26M

Sector Composition

Rank Sector Weight
1 Healthcare 29.46%
2 Consumer Discretionary 27.3%
3 Technology 25.78%
4 Financials 8.49%
5 Communication Services 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TSLA icon
1
Tesla
TSLA
$1.48T
$103M 18.92%
228,500
-15,500
-6% -$6.87M
2022 Q4
12 quarters
SHOP icon
2
Shopify
SHOP
$227B
$66M 12.15%
410,000
-5,000
-1% -$803K
2021 Q4
16 quarters
SPOT icon
3
Spotify
SPOT
$108B
$39.5M 7.27%
68,000
-27,000
-28% -$16.9M
2021 Q4
16 quarters
PLTR icon
4
Palantir
PLTR
$501B
$35.5M 6.55%
200,000
– –
2023 Q2
10 quarters
AMZN icon
5
Amazon
AMZN
$2.79T
$27.9M 5.14%
121,000
-28,000
-19% -$6.41M
2022 Q3
13 quarters
ARWR icon
6
Arrowhead Research
ARWR
$8.21B
$26.4M 4.87%
398,204
-75,747
-16% -$3.71M
2021 Q4
16 quarters
IONS icon
7
Ionis Pharmaceuticals
IONS
$7.04B
$19.1M 3.51%
240,824
-8,070
-3% -$608K
2021 Q4
16 quarters
COIN icon
8
Coinbase
COIN
$48B
$17.9M 3.29%
79,000
– –
2025 Q2
2 quarters
LMND icon
9
Lemonade
LMND
$3.46B
$17.7M 3.25%
248,259
+103,259
+71% +$6.94M
2025 Q3
1 quarter
SE icon
10
Sea Limited
SE
$58.8B
$17.6M 3.24%
138,000
-22,000
-14% -$3.26M
2023 Q2
10 quarters
NVDA icon
11
NVIDIA
NVDA
$5.52T
$15.1M 2.78%
81,000
– –
2023 Q1
11 quarters
BIIB icon
12
Biogen
BIIB
$33.8B
$12.9M 2.38%
73,480
+21,555
+42% +$3.52M
2025 Q2
2 quarters
AMD icon
13
Advanced Micro Devices
AMD
$989B
$12.8M 2.37%
60,000
– –
2025 Q3
1 quarter
PRQR icon
14
ProQR Therapeutics
PRQR
$209M
$10.8M 1.99%
5,357,762
+359,475
+7% +$840K
2021 Q4
16 quarters
IREN icon
15
Iris Energy
IREN
$13.7B
$10.6M 1.95%
280,000
+150,000
+115% +$7.74M
2025 Q3
1 quarter
ASTS icon
16
AST SpaceMobile
ASTS
$14.1B
$10.5M 1.94%
145,000
+35,000
+32% +$2.5M
2025 Q3
1 quarter
AXSM icon
17
Axsome Therapeutics
AXSM
$8.19B
$10.4M 1.91%
56,878
+4,146
+8% +$579K
2023 Q1
11 quarters
QURE icon
18
uniQure
QURE
$1.48B
$9.96M 1.83%
416,270
+30,270
+8% +$1.17M
2021 Q4
16 quarters
ARQT icon
19
Arcutis Biotherapeutics
ARQT
$3.28B
$8.89M 1.64%
305,972
– –
2024 Q4
4 quarters
RARE icon
20
Ultragenyx Pharmaceutical
RARE
$1.47B
$8.22M 1.51%
357,502
+67,698
+23% +$2.23M
2021 Q4
16 quarters
VRDN icon
21
Viridian Therapeutics
VRDN
$2.06B
$5.4M 0.99%
+173,516
New +$4.76M
2025 Q4
0 quarters
URGN icon
22
UroGen Pharma
URGN
$1.87B
$5.03M 0.93%
214,622
+18,000
+9% +$390K
2024 Q4
4 quarters
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$123B
$4.24M 0.78%
9,355
+1,055
+13% +$455K
2025 Q1
3 quarters
MRK icon
24
Merck
MRK
$350B
$3.85M 0.71%
36,593
-27,800
-43% -$2.61M
2021 Q4
16 quarters
WVE icon
25
Wave Life Sciences
WVE
$619M
$3.28M 0.6%
193,010
+23,010
+14% +$234K
2024 Q3
5 quarters
1
2 3

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, Privium Fund Management held 65 positions worth $543M, down 2.4% from $556M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Privium Fund Management's Q4 2025 filing shows 6 new, 25 increased, 15 reduced and 8 closed positions. Its largest new stake was Viridian Therapeutics: 173,516 shares worth $5.4M. The largest sale was Spotify, an estimated $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Privium Fund Management's largest Q4 2025 buy was Viridian Therapeutics: 173,516 shares worth $5.4M.
  • Privium Fund Management added most to Iris Energy in Q4 2025, an estimated $7.74M increase.
  • Privium Fund Management's biggest Q4 2025 reduction was Spotify, cutting an estimated $16.9M.
  • Privium Fund Management fully exited Abivax in Q4 2025, selling an estimated $2.58M.
  • Privium Fund Management's ten largest holdings make up 68% of its $543M portfolio in Q4 2025.
  • Privium Fund Management opened 6 new positions and closed 8 in Q4 2025.
  • Privium Fund Management's portfolio value fell 2.4% quarter-over-quarter to $543M.

Based on Privium Fund Management's 13F filing for Q4 2025, filed 3 Feb 2026.